Found: 14
Select item for more details and to access through your institution.
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
- Published in:
- BMC Medical Genomics, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s12920-015-0129-6
- By:
- Publication type:
- Article
Characterization and Application of Osmotic Dewatering to the Crystallization of Oligonucleotides.
- Published in:
- Biotechnology Progress, 1997, v. 13, n. 1, p. 77, doi. 10.1021/bp960087l
- By:
- Publication type:
- Article
Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 159, n. 1, p. 71, doi. 10.1007/s10549-016-3868-y
- By:
- Publication type:
- Article
Intrinsic Subtype and Therapeutic Response Among HER2-Positive Breast Tumors from the NCCTG (Alliance) N9831 Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Factors predicting late recurrence for estrogen receptor-positive breast cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Factors Predicting Late Recurrence for Estrogen Receptor–Positive Breast Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 19, p. 1504, doi. 10.1093/jnci/djt244
- By:
- Publication type:
- Article
The Prosigna gene expression assay and responsiveness to adjuvant cyclophosphamide-based chemotherapy in premenopausal high-risk patients with breast cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Corrigendum: Direct multiplexed measurement of gene expression with color-coded probe pairs.
- Published in:
- 2008
- By:
- Publication type:
- Correction notice
Direct multiplexed measurement of gene expression with color-coded probe pairs.
- Published in:
- Nature Biotechnology, 2008, v. 26, n. 3, p. 317, doi. 10.1038/nbt1385
- By:
- Publication type:
- Article
The ability of PAM50 risk of recurrence score to predict 10-year distant recurrence in hormone receptor-positive postmenopausal women with special histological subtypes.
- Published in:
- Acta Oncologica, 2018, v. 57, n. 1, p. 44, doi. 10.1080/0284186X.2017.1403044
- By:
- Publication type:
- Article
The Prosigna 50-gene profile and responsiveness to adjuvant anthracycline-based chemotherapy in high-risk breast cancer patients.
- Published in:
- NPJ Breast Cancer, 2020, v. 6, n. 1, p. 1, doi. 10.1038/s41523-020-0148-0
- By:
- Publication type:
- Article
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
- Published in:
- BMC Cancer, 2014, v. 14, p. 1, doi. 10.1186/1471-2407-14-177
- By:
- Publication type:
- Article
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article